SRR

Red Cat Launches Robotics and Autonomous Systems Consortium to Bridge Critical UAS Technology Gaps for Warfighters

Retrieved on: 
Tuesday, May 7, 2024

RFI is an independent, industry-wide consortium of robotics and autonomous systems (RAS) partners dedicated to putting the most advanced and interoperable uncrewed aircraft systems into the hands of warfighters.

Key Points: 
  • RFI is an independent, industry-wide consortium of robotics and autonomous systems (RAS) partners dedicated to putting the most advanced and interoperable uncrewed aircraft systems into the hands of warfighters.
  • Founding members include Ocean Power Technologies (NYSE: OPTT), Sentien Robotics , Primordial Labs , Athena AI , Unusual Machines , Reach Power , and MMS Products .
  • The shared goal is advocacy, integrations and co-marketing that bridges considerable technology gaps through modular open architecture.
  • “The need for the UAS sector to move quickly to meet the requirements of Replicator is more urgent than ever,” said Jeff Thompson, Red Cat CEO.

Global Military Drone Market Expected to Reach $18 Billion By 2028 as U.S. Government Plays Crucial Role in Military Drone Industry

Retrieved on: 
Tuesday, May 7, 2024

According to a report from MarketsAndMarkets, the military drone market is poised to reach USD 18.2 billion by 2028, with a Compound Annual Growth Rate (CAGR) of 7.0% during the period from 2023 to 2028.

Key Points: 
  • According to a report from MarketsAndMarkets, the military drone market is poised to reach USD 18.2 billion by 2028, with a Compound Annual Growth Rate (CAGR) of 7.0% during the period from 2023 to 2028.
  • The report said: “The global race among nations to invest in drone technology has sparked a competitive environment.
  • This demand for more sophisticated drone capabilities is a key factor stimulating the expansion of the military drone market.
  • The MarketsAndMarkets report continued: “Based on operation mode, The military drone market is divided into remotely piloted, optionally piloted, and fully autonomous categories.

Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress

Retrieved on: 
Wednesday, May 8, 2024

“Arcturus continues to make encouraging progress in both our vaccine and therapeutics pipeline,” said Joseph Payne, President & CEO of Arcturus.

Key Points: 
  • “Arcturus continues to make encouraging progress in both our vaccine and therapeutics pipeline,” said Joseph Payne, President & CEO of Arcturus.
  • To support this effort, Arcturus along with CDMO partners are on track to deliver the initial 4 million commercial doses of Kostaive in Q3.
  • The Company will share a progress update on the Phase 2 study on July 1, 2024.
  • The expected cash runway extends at least three years based on the current pipeline and programs through the first quarter of fiscal year 2027.

X-Bow Systems Advances Affordable Hypersonics with Key Milestone on Large Solid Rocket Motor Program

Retrieved on: 
Monday, May 6, 2024

ALBUQUERQUE, N.M., May 6, 2024 /PRNewswire/ -- X-Bow Systems Inc (X-Bow) has completed the System Requirements Review (SRR) for the Large Solid Rocket Motor (LSRM) program on schedule.

Key Points: 
  • ALBUQUERQUE, N.M., May 6, 2024 /PRNewswire/ -- X-Bow Systems Inc (X-Bow) has completed the System Requirements Review (SRR) for the Large Solid Rocket Motor (LSRM) program on schedule.
  • The X-Bow team is now proceeding with preliminary design, critical component qualification activities, and material procurement.
  • "Affordable weapon systems are crucial for ensuring accessible defense capabilities.
  • Achieving this milestone signifies X-Bow's commitment of innovation, paired with shortened design and development timelines, and a focus on affordability," stated Tony Spidale, X-Bow LSRM Program Director.

Red Cat Successfully Passes Field Testing with Doodle Labs Against Electronic Warfare Technology in Ukraine

Retrieved on: 
Thursday, April 25, 2024

SAN JUAN, Puerto Rico, April 25, 2024 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) ("Red Cat"), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announced it has successfully passed electronic warfare (EW) testing in Ukraine with Doodle Labs.

Key Points: 
  • SAN JUAN, Puerto Rico, April 25, 2024 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) ("Red Cat"), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announced it has successfully passed electronic warfare (EW) testing in Ukraine with Doodle Labs.
  • The successful test is part of a continuous innovation cycle that began in May 2023 with a partnership between Doodle Labs and Red Cat for its U.S. Army Short Range Reconnaissance (SRR) program prototype.
  • The ongoing partnership between Red Cat and Doodle Labs is addressing the growing need by the U.S. and its allies for small, autonomous, and attritable drones equipped with anti-jamming radios capable of operating in electronic warfare.
  • Teal systems with Doodle Labs frequency-hopping radios can evade jamming attempts and are usable in multi-domain environments for surveillance and swarming operations.

Linnaeus Therapeutics Announces Issuance of Composition of Matter Patent for LNS8801 by the European Patent Office

Retrieved on: 
Tuesday, April 2, 2024

HADDONFIELD N.J., April 2, 2024 /PRNewswire/ -- Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics, today announced that on March 6, 2024, the European Patent Office (EPO) issued EP patent 3,823,617 ('617 patent) covering the pharmaceutical composition of matter for the company's lead compound, LNS8801.

Key Points: 
  • European Patent 3,823,617 Issued on March 6, 2024
    HADDONFIELD N.J., April 2, 2024 /PRNewswire/ -- Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics, today announced that on March 6, 2024, the European Patent Office (EPO) issued EP patent 3,823,617 ('617 patent) covering the pharmaceutical composition of matter for the company's lead compound, LNS8801.
  • "We are extremely pleased that the EPO has issued this composition of matter patent," commented Patrick Mooney, MD, CEO of Linnaeus.
  • As we continue to collect very promising data from our clinical trials with LNS8001, we will continue to prosecute the claims in this patent worldwide."
  • The study will enroll 135 patients who will be selected based on a predictive biomarker and then randomized to receive LNS8801 alone, LNS8801 and pembrolizumab, or physician's choice therapy.

Successful Completion of System Requirements & Design Review Demonstrates Progress Toward Q4 Launch of Innovative Precision Positioning, Navigation and Timing Payload

Retrieved on: 
Tuesday, February 20, 2024

The SRR and SDR are important program milestones marking the baselining of the requirements for the mission and design of the navigation payload into Sidus’ commercially developed, owned, and operated small satellite.

Key Points: 
  • The SRR and SDR are important program milestones marking the baselining of the requirements for the mission and design of the navigation payload into Sidus’ commercially developed, owned, and operated small satellite.
  • The SRR reviewed team specifications to ensure they reflect the current knowledge of the mission and market requirements to serve as a stable baseline to proceed with development.
  • The Sidus team is maturing the design of its customer’s payload for an expected integration for launch later this year.
  • All parties agreed the LS-3 integrated architecture safely meets approved mission success criteria on schedule and within budget.

Red Cat Reports Preliminary Record Revenue 16% Above Guidance for Third Quarter of Fiscal 2024 and Increases Guidance for Fourth Quarter 2024

Retrieved on: 
Wednesday, February 14, 2024

“We had record shipments of the Teal 2 in the third quarter, as our backlog hit a new company record.

Key Points: 
  • “We had record shipments of the Teal 2 in the third quarter, as our backlog hit a new company record.
  • We expect fourth quarter to be an exciting and fruitful quarter after the last 12 months of business development in NATO countries and Saudi Arabia.”
    “Teal’s autonomous, attritable, and open technology is seeing huge demand in America and around the world,” said George Matus, CTO of Red Cat.
  • “We develop vertically integrated products and scale them through volume production in our brand new factory in Salt Lake City.
  • Red Cat is here to fully support the warfighter and the paradigm shift actively happening toward our technology with programs like SRR, Replicator, and beyond.”

Red Cat Integrates Advanced AI Capabilities into Next-Generation Drone System for the U.S. Army’s Short Range Reconnaissance Program

Retrieved on: 
Tuesday, January 23, 2024

Teal was recently selected by the Department of Defense’s Defense Innovation Unit and the U.S. Army as one of two finalists competing in the SRR program.

Key Points: 
  • Teal was recently selected by the Department of Defense’s Defense Innovation Unit and the U.S. Army as one of two finalists competing in the SRR program.
  • The program’s goal is to provide small, rucksack-portable sUAS capabilities to Army platoons for situational awareness beyond the next terrain feature.
  • “Teal’s solution is the first to integrate this kind of advanced artificial intelligence and real-time processing onboard the aircraft itself.
  • It is both Blue UAS Certified, which indicates its approval by the Department of Defense, and FAA Remote ID approved.

Skydio Enters Final Phase of U.S. Army’s Short Range Reconnaissance Tranche 2 Program

Retrieved on: 
Wednesday, January 10, 2024

Skydio , the leading U.S. drone manufacturer and world leader in autonomous flight technology, today announced it has entered into the final phase of the U.S. Army’s Short Range Reconnaissance (SRR) tranche 2 program, where it intends to deliver the powerful Skydio X10D small UAS (sUAS), the next generation of autonomous drone technology.

Key Points: 
  • Skydio , the leading U.S. drone manufacturer and world leader in autonomous flight technology, today announced it has entered into the final phase of the U.S. Army’s Short Range Reconnaissance (SRR) tranche 2 program, where it intends to deliver the powerful Skydio X10D small UAS (sUAS), the next generation of autonomous drone technology.
  • Skydio remains the solution provider of record for the U.S. Army’s Short Range Reconnaissance program, which it won in November 2021 .
  • The Skydio X10 platform combines new, cutting-edge data capture cameras, unparalleled autonomy, and versatile hardware to serve a range of industries, including defense, public safety, and utilities.
  • The SRR program is designed to equip soldiers with a rapidly deployable small UAS solution to conduct reconnaissance and surveillance (R&S) activities.